跳至主要内容
临床试验/JPRN-jRCT2063220014
JPRN-jRCT2063220014进行中(未招募)2 期

Evaluate efficacy and safety of umbilical cord-derived mesenchymal stromal cells (HLC-001) for patient with Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation

Morio Ikeda0 个研究点目标入组 12 人开始时间: 2022年5月10日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Patients to meet the IPS criteria by American Thoracic Society
  • 2. Patients that the disease worsens after the treatment of more than 1mg/kg/day of corticosteroid (prednisolone equivalent) for 3 days or later, or patients that do not improve the disease after the treatment of more than 1 mg/kg/day of corticosteroid for 5 days
  • 3. 16 years or older when informed consent is obtained

排除标准

  • 1.Evidence of active infectious pneumonitis
  • 2.Respiration failure due to cardiac arrest (Enlargement of heart mental shadows and left ventricular ejection fraction that is less than 45%)
  • 3.Patients that received or has received the following medications for concurrent diseases
  • 1)Bone Marrow-derived Mesenchymal Stem Cell
  • 2)Inhibitor of Bruton tyrosine kinase (BTK)
  • Or patients that clearly need the following medications, therapies after enrollment
  • 1)Other systemic immunosuppressant medical treatments
  • 2)Increment of corticosteroid except for the use as needed for allergic reaction
  • 4.Patients that received therapies for cancer within 3 months of enrollment except for hematopoietic cell transplantation or patients with unstable condition of cancer although therapies were completed more than 3 months before enrollment
  • 5.History of acute myocardial infarction within 3 months before enrollment
  • 6.Medical History or complication of primary pulmonary hypertension
  • 7.The following laboratory test result within 14 days before enrollment except for abnormality to be caused by GVHD
  • 1)Serum total bilirubin (TB), 3 times of upper limit of institutional normal range
  • 2)Aspartate aminotransferase (AST)and Alanine aminotransferase (ALT), 5 times of upper limit of institutional normal range
  • 3)Serum creatinine, 2 times of upper limit of institutional normal range

研究者

发起方
Morio Ikeda

相似试验